"Philips Halts US Sleep Apnea Device Sales Following FDA Agreement"
TL;DR Summary
Philips has stopped the sale of its sleep apnoea machines and ventilators in the US after reaching an agreement with the Food and Drug Administration (FDA). The decision comes after the FDA raised concerns about potential health risks associated with the foam used in the devices. The company has advised users to consult with their physicians before making any changes to their treatment and is working to address the issue and provide replacement and repair services.
- Philips halts sleep apnoea device sales in US after FDA deal Financial Times
- Philips' U.S. sales of sleep apnea devices face years-long halt after FDA deal CNBC
- Philips announces its 2023 Fourth-Quarter and Annual Results Philips
- Philips Halts Sale of Sleep Apnea Gear in US After FDA Deal Bloomberg
- Philips' US sales of sleep apnea devices face years-long halt after FDA deal Reuters
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
45%
138 → 76 words
Want the full story? Read the original article
Read on Financial Times